JapanStake
Pharmaceutical · Fiscal year end 12月末日

Innovacell Inc.

504A

イノバセル株式会社

FIGI BBG01R6YDLR8504A.T504A JPCorp. no. 1011001137886

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-06

For the first half of the fiscal year to 2026-12: Ordinary income ¥-1.6 billion, Net income ¥-1.6 billion.

This periodYear on year
Ordinary profit−¥1.6bn—
Net profit to owners−¥1.6bn—

From the securities report on EDINET, which states no forecast. History via /v1/companies/504A/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2025-12-31
Revenue
—
Net income
−¥2.9bn
ROE
—
Equity ratio
—
Dividend / share
—
Employees
48
Net income · ¥bn
FY2023: −¥2.0bn -2 FY2023FY2024: −¥2.4bn -2.39 FY2024FY2025: −¥2.9bn -2.86 FY2025
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2025-12-31—−¥2,855m¥5,093m−¥630m—¥-89−¥1,995m
2024-12-31—−¥2,392m¥2,835m−¥1,956m—¥-89.42−¥1,298m
2023-12-31—−¥2,002m¥2,404m−¥1,738m—¥-75.39−¥1,407m

Indicators

Computed by us from filings · fiscal year to 2025-12-31
MetricValuePercentile among listed companies
ROE, %——
Ordinary margin——
Equity ratio, %——
Revenue growth——
Net income growth-0.193423
Operating cash flow / assets-0.39181
Policy-uncertainty measure0.38 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 1 Fiscal & tax 1 Politics & geopolitics 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 4.2% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/504A/indicators. Descriptive figures, not a rating and not investment advice.

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-03-26 · 資本準備金の額の減少並びに剰余金の処分の件 · passed. /v1/companies/504A/voting

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥685¥967¥1,249 2026-02-242026-05-22 2026-05-22 · bought 20,800 @ ¥685 · individual filer2026-02-24 · sold 110 @ ¥1,249 · individual filer2026-02-24 · sold 110 @ ¥1,249 · individual filer
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2026-02-24 – 2026-05-22+20,690+0.05pt¥687.97¥685–1,249
individual filer2026-02-24 – 2026-02-24-1100.00pt¥1,249¥1,249–1,249

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/504A/trades.

5% filings

Large shareholding reports on 504A
FiledFilerStakeChangeStated purpose
2026-06-08individual filer5.41%−0.08ptmanagement participation
2026-03-06M&G Investment Management Limited8.99%—pure investment
2026-03-03individual filer6.11%—pure investment
2026-03-02individual filer5.49%—management participation
2026-03-02individual filer5.49%—management participation
2026-03-02individual filer5.25%—management participation
2026-03-02INSANNA Stiftung8.18%——
2026-02-26Peppermint Grove Limited8.19%——
2026-02-25Peppermint Grove Limited8.19%−1.26pt—

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
1

Held by: Alfresa Holdings Corporation 2784

Purposes, all holdings and mutual flags via /v1/companies/504A/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31
ShareholderSharesRatio
Peppermint Grove Limited3,609,81510.83%
individual holder3,607,98810.82%
シーズ・インベストメント有限責任事業組合2,464,1007.39%
individual holder2,291,7216.87%
individual holder2,291,7216.87%
individual holder2,140,6286.42%
individual holder1,643,9144.93%
Glymur Biotech Ventures LP1,339,5084.02%
アルフレッサ株式会社1,176,4713.53%
individual holder791,7002.37%

Get this as JSON

GET /v1/companies/504A
GET /v1/companies/504A/financials
GET /v1/companies/504A/details
GET /v1/companies/504A/segments
GET /v1/companies/504A/voting
GET /v1/companies/504A/tender-offers
GET /v1/companies/504A/indicators
GET /v1/companies/504A/earnings-releases
GET /v1/events?ticker=504A
GET /v1/companies/504A/trades         
GET /v1/companies/504A/cross-holdings 
GET /v1/companies/504A/brief          

Plans from $9 a month · Documentation